Tectonic Therapeutics TECX US — Income Tax Reconciliation Tax Credits Research
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.
The official record: Tectonic Therapeutics’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tectonic Therapeutics's us — income tax reconciliation tax credits research.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tectonic Therapeutics's US — income tax reconciliation tax credits research?
- Tectonic Therapeutics (TECX) reported US — income tax reconciliation tax credits research of $2.98M in Q4 2025.
- What does US — income tax reconciliation tax credits research mean?
- This metric represents the total value of tax credits claimed by the company's US operations specifically related to research and development activities. It serves as a financial indicator of the company's investment in innovation and its ability to utilize government tax incentives to offset operational costs. Tracking this figure helps investors understand the tax-shield benefits derived from the company's ongoing R&D pipeline and scientific discovery efforts.